Cargando…
Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer
Our recent study of the microRNA (miRNA) expression signature of bladder cancer (BC) by deep‐sequencing revealed that two miRNA, microRNA‐139‐5p/microRNA‐139‐3p were significantly downregulated in BC tissues. The aim of this study was to investigate the functional roles of these miRNA and their modu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021030/ https://www.ncbi.nlm.nih.gov/pubmed/27355528 http://dx.doi.org/10.1111/cas.13002 |
_version_ | 1782453290062053376 |
---|---|
author | Yonemori, Masaya Seki, Naohiko Yoshino, Hirofumi Matsushita, Ryosuke Miyamoto, Kazutaka Nakagawa, Masayuki Enokida, Hideki |
author_facet | Yonemori, Masaya Seki, Naohiko Yoshino, Hirofumi Matsushita, Ryosuke Miyamoto, Kazutaka Nakagawa, Masayuki Enokida, Hideki |
author_sort | Yonemori, Masaya |
collection | PubMed |
description | Our recent study of the microRNA (miRNA) expression signature of bladder cancer (BC) by deep‐sequencing revealed that two miRNA, microRNA‐139‐5p/microRNA‐139‐3p were significantly downregulated in BC tissues. The aim of this study was to investigate the functional roles of these miRNA and their modulation of cancer networks in BC cells. Functional assays of BC cells were performed using transfection of mature miRNA or small interfering RNA (siRNA). Genome‐wide gene expression analysis, in silico analysis and dual‐luciferase reporter assays were applied to identify miRNA targets. The associations between the expression of miRNA and its targets and overall survival were estimated by the Kaplan–Meier method. Gain‐of‐function studies showed that miR‐139‐5p and miR‐139‐3p significantly inhibited cell migration and invasion by BC cells. The matrix metalloprotease 11 gene (MMP11) was identified as a direct target of miR‐139‐5p and miR‐139‐3p. Kaplan–Meier survival curves showed that higher expression of MMP11 predicted shorter survival of BC patients (P = 0.029). Downregulated miR‐139‐5p or miR‐139‐3p enhanced BC cell migration and invasion in BC cells. MMP11 was directly regulated by these miRNA and might be a good prognostic marker for survival of BC patients. |
format | Online Article Text |
id | pubmed-5021030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-50210302016-09-20 Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer Yonemori, Masaya Seki, Naohiko Yoshino, Hirofumi Matsushita, Ryosuke Miyamoto, Kazutaka Nakagawa, Masayuki Enokida, Hideki Cancer Sci Original Articles Our recent study of the microRNA (miRNA) expression signature of bladder cancer (BC) by deep‐sequencing revealed that two miRNA, microRNA‐139‐5p/microRNA‐139‐3p were significantly downregulated in BC tissues. The aim of this study was to investigate the functional roles of these miRNA and their modulation of cancer networks in BC cells. Functional assays of BC cells were performed using transfection of mature miRNA or small interfering RNA (siRNA). Genome‐wide gene expression analysis, in silico analysis and dual‐luciferase reporter assays were applied to identify miRNA targets. The associations between the expression of miRNA and its targets and overall survival were estimated by the Kaplan–Meier method. Gain‐of‐function studies showed that miR‐139‐5p and miR‐139‐3p significantly inhibited cell migration and invasion by BC cells. The matrix metalloprotease 11 gene (MMP11) was identified as a direct target of miR‐139‐5p and miR‐139‐3p. Kaplan–Meier survival curves showed that higher expression of MMP11 predicted shorter survival of BC patients (P = 0.029). Downregulated miR‐139‐5p or miR‐139‐3p enhanced BC cell migration and invasion in BC cells. MMP11 was directly regulated by these miRNA and might be a good prognostic marker for survival of BC patients. John Wiley and Sons Inc. 2016-09-06 2016-09 /pmc/articles/PMC5021030/ /pubmed/27355528 http://dx.doi.org/10.1111/cas.13002 Text en © 2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Yonemori, Masaya Seki, Naohiko Yoshino, Hirofumi Matsushita, Ryosuke Miyamoto, Kazutaka Nakagawa, Masayuki Enokida, Hideki Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer |
title | Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer |
title_full | Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer |
title_fullStr | Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer |
title_full_unstemmed | Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer |
title_short | Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer |
title_sort | dual tumor‐suppressors mir‐139‐5p and mir‐139‐3p targeting matrix metalloprotease 11 in bladder cancer |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021030/ https://www.ncbi.nlm.nih.gov/pubmed/27355528 http://dx.doi.org/10.1111/cas.13002 |
work_keys_str_mv | AT yonemorimasaya dualtumorsuppressorsmir1395pandmir1393ptargetingmatrixmetalloprotease11inbladdercancer AT sekinaohiko dualtumorsuppressorsmir1395pandmir1393ptargetingmatrixmetalloprotease11inbladdercancer AT yoshinohirofumi dualtumorsuppressorsmir1395pandmir1393ptargetingmatrixmetalloprotease11inbladdercancer AT matsushitaryosuke dualtumorsuppressorsmir1395pandmir1393ptargetingmatrixmetalloprotease11inbladdercancer AT miyamotokazutaka dualtumorsuppressorsmir1395pandmir1393ptargetingmatrixmetalloprotease11inbladdercancer AT nakagawamasayuki dualtumorsuppressorsmir1395pandmir1393ptargetingmatrixmetalloprotease11inbladdercancer AT enokidahideki dualtumorsuppressorsmir1395pandmir1393ptargetingmatrixmetalloprotease11inbladdercancer |